<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005227A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005227</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13992582</doc-number><date>20111208</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>401</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>401</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514338</main-classification><further-classification>5462757</further-classification></classification-national><invention-title id="d0e43">CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>61421323</doc-number><date>20101209</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Kling</last-name><first-name>Andreas</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Jantos</last-name><first-name>Katja</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Mack</last-name><first-name>Helmut</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Moller</last-name><first-name>Achim</first-name><address><city>Wiesbaden</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Hornberger</last-name><first-name>Wilfried</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>Lao</last-name><first-name>Yanbin</first-name><address><city>North Chicago</city><state>IL</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="06" app-type="applicant" designation="us-only"><addressbook><last-name>Backfisch</last-name><first-name>Gisela</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook><residence><country>DE</country></residence></us-applicant><us-applicant sequence="07" app-type="applicant" designation="us-only"><addressbook><last-name>Nijsen</last-name><first-name>Marjoleen</first-name><address><city>North Chicago</city><state>IL</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Kling</last-name><first-name>Andreas</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Jantos</last-name><first-name>Katja</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Mack</last-name><first-name>Helmut</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Moller</last-name><first-name>Achim</first-name><address><city>Wiesbaden</city><country>DE</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Hornberger</last-name><first-name>Wilfried</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Lao</last-name><first-name>Yanbin</first-name><address><city>North Chicago</city><state>IL</state><country>US</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>Backfisch</last-name><first-name>Gisela</first-name><address><city>Ludwigshafen</city><country>DE</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>Nijsen</last-name><first-name>Marjoleen</first-name><address><city>North Chicago</city><state>IL</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>ABBVIE Deutschland GmbH &#x26; Co. KG</orgname><role>03</role><address><city>Wiesbaden</city><country>DE</country></address></addressbook></assignee></assignees><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/EP2011/072164</doc-number><kind>00</kind><date>20111208</date></document-id><us-371c124-date><date>20130905</date></us-371c124-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, X, m and n have the meanings mentioned in the claims and the description, the tautomers thereof, the hydrates thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein R<sup>1 </sup>is optionally substituted benzyl or hetaryl-methyl, X is a single bond or an oxygen atom, R<sup>2 </sup>is C<sub>1</sub>-C<sub>4</sub>-alkyl, C<sub>1</sub>-C<sub>4</sub>-haloalkyl, C<sub>2</sub>-C<sub>4</sub>-alkenyl, C<sub>3</sub>-C<sub>6</sub>-cycloalkyl, C<sub>3</sub>-C<sub>6</sub>-cycloalkyl-C<sub>1</sub>-C<sub>2</sub>-alkyl, C<sub>3</sub>-C<sub>6</sub>-heterocycloalkyl-C<sub>1</sub>-C<sub>2</sub>-alkyl, phenyl, phenyl-C<sub>1</sub>-C<sub>3</sub>-alkyl, pyridin-2-yl-C<sub>1</sub>-C<sub>3</sub>-alkyl or CH<sub>2</sub>&#x2014;C(O)OCH<sub>3</sub>, R<sup>3 </sup>and R<sup>4 </sup>independently of one another are halogen, CN, CF<sub>3</sub>, CHF<sub>2</sub>, CH<sub>2</sub>F, C<sub>1</sub>-C<sub>2</sub>-alkyl or C<sub>1</sub>-C<sub>2</sub>-alkoxy, and m and n independently of one another are 0 or 1.</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="44.45mm" wi="69.85mm" file="US20140005227A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p></abstract></us-patent-application>